(NYSE: GKOS) Glaukos's forecast annual revenue growth rate of 20.06% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.62%.
Glaukos's revenue in 2025 is $432,953,000.On average, 7 Wall Street analysts forecast GKOS's revenue for 2025 to be $27,711,743,118, with the lowest GKOS revenue forecast at $27,640,973,234, and the highest GKOS revenue forecast at $27,747,070,710. On average, 7 Wall Street analysts forecast GKOS's revenue for 2026 to be $34,907,847,437, with the lowest GKOS revenue forecast at $34,366,406,210, and the highest GKOS revenue forecast at $35,792,126,887.
In 2027, GKOS is forecast to generate $43,166,016,165 in revenue, with the lowest revenue forecast at $42,492,325,868 and the highest revenue forecast at $44,860,306,831.